NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Rosuvastatin


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data from Queen's University provide new insights into life sciences
2009 SEP 15 ... into sharper focus the question-'What is medicine for ?' The international study of rosuvastatin is important not simply because of the health benefits it may confer, but because it ...
Subject: Life Sciences
Price: $3.00
*
Data on pharmacokinetics described by researchers at University of Helsinki
2009 SEP 7 ... of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin,' is newly published data in British Journal of Clinical Pharmacology. "This study ...
Subject: Pharmacokinetics
Price: $3.00
*
Generic Medicine Is Cost Effective
2009 NOV 1 ... THERE IS NO GENERIC VERSION OF THE CHOLESTEROL MEDICATION CRESTOR=AE (ROSUVASTATIN CALCIUM). CRESTOR, ALONG WITH DIET, IS INDICATED TO SLOW THE PROGRESSION OF ...
Subject: Pharmaceuticals
Price: $3.00
*
New atrial fibrillation data have been reported by scientists at Research Center
2009 OCT 19 ... Researchers detail in 'Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial,' new data ...
Subject: Atrial Fibrillation
View Free
Daily News
Article
New HIV/AIDS research has been reported by K. Falasca et al
2009 NOV 1 ... patient who had severe hypertriglyceridaemia and bad metabolic parameters treated with rosuvastatin and OM-3 fatty acids," wrote K. Falasca and colleagues. The researchers ...
Subject: HIV/AIDS
Price: $3.00
*
New pharmacokinetics research has been reported by P.A. Pham et al
2009 NOV 16 ... pharmacokinetic (PK) drug-drug interactions between tipranavir-ritonavir (TPV/r) and rosuvastatin and atorvastatin, we conducted two prospective, open-label, single-arm, two-period ...
Subject: Pharmacokinetics
Price: $3.00
*
Research in the area of heart failure reported from University of Queensland
2009 NOV 9 ... Australia, "3-hydroxy-3-methylglutaryl(HMG)-Coenzyme(Co)A reductase inhibitors such as rosuvastatin may improve clinical status in patients with hypertension and heart failure. The aging ...
Subject: Heart Failure
Price: $3.00
*
Researchers at La Sapienza University publish new data on life sciences
2009 SEP 7 ... of the antiplatelet effect of clopidogrel. We thus sought to assess the influence of rosuvastatin on clopidogrel antiplatelet action in high-risk (HR) cardiovascular patients," ...
Subject: Life Sciences
Price: $3.00
*
Researchers from Karolinska University, Karolinska Institute describe findings in atorvastatin
2009 NOV 2 ... of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment' have been presented. "Possible ...
Subject: Atorvastatin
Price: $3.00
*
Researchers from Seoul National University publish new studies and findings in the area of heart failure
2009 OCT 5 ... the favorable effect of statins on LVH." "We evaluated the effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in a hypertensive rat ...
Subject: Heart Failure
Price: $3.00
*
Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin
2009 NOV 23 ... in China, announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical Co., Ltd. ("Tianda"). The acquisition of the ...
Subject: Pharmaceuticals
Price: $3.00
*
Studies from B. Yavuz et al provide new data on life sciences
2009 OCT 5 ... and vitamin D. The aim of this study was to investigate the possible effect of rosuvastatin on vitamin D metabolism," investigators in Ankara, Turkey report. "The ...
Subject: Life Sciences
Price: $3.00
*
Studies from University of Helsinki yield new information about pharmacokinetics
2009 SEP 14 ... a pharmacokinetic crossover study involving the administration of 20 mg atorvastatin and rosuvastatin. The frequency of the c.421A variant allele was 9.5% (95% confidence interval ...
Subject: Pharmacokinetics
Price: $3.00
*
Studies from University of Missouri, Medical Department provide new data on hypertension
2009 NOV 1 ... RI, Sowers JR, Andresen BT, Gutweiler AA, Ma L, Johnson MS, Ferrario CM, Dellsperger KC. Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic ...
Subject: Hypertension
Price: $3.00
*
Studies in the area of diabetes reported from University of Ioannina, Medical Department
2009 SEP 28 ... "of the study: The increase in physician-reported diabetes following rosuvastatin treatment in the Justification for the Use of Statins in Prevention: an Intervention ...
Subject: Diabetes
Price: $3.00
*
U.S. Food and Drug Administration Approves CRESTOR for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
2009 NOV 1 ... AZN) announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial ...
Subject: AstraZeneca
Price: $3.00
*
U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
2009 NOV 1 ... (NYSE: AZN) announced the U.S. Food and Drug Administration (FDA) approved CRESTOR=AE (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial ...
Subject: Familial Hypercholesterolemia
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login